The Consequences of Oromandibular Dystonia on Communicative Participation: A Qualitative Study of the Insider\u27s Experiences by Siegel, Lauren
Western University 
Scholarship@Western 
Electronic Thesis and Dissertation Repository 
7-15-2016 12:00 AM 
The Consequences of Oromandibular Dystonia on Communicative 
Participation: A Qualitative Study of the Insider's Experiences 
Lauren Siegel 
The University of Western Ontario 
Supervisor 
Dr. Allyson Dykstra 
The University of Western Ontario 
Graduate Program in Communication Sciences and Disorders 
A thesis submitted in partial fulfillment of the requirements for the degree in Master of Science 
© Lauren Siegel 2016 
Follow this and additional works at: https://ir.lib.uwo.ca/etd 
 Part of the Communication Sciences and Disorders Commons 
Recommended Citation 
Siegel, Lauren, "The Consequences of Oromandibular Dystonia on Communicative Participation: A 
Qualitative Study of the Insider's Experiences" (2016). Electronic Thesis and Dissertation Repository. 
3925. 
https://ir.lib.uwo.ca/etd/3925 
This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted 
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of 
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca. 
  i 
Abstract 
The purpose of this study was to explore the consequences of oromandibular dystonia 
(OMD) on communicative participation from the insider’s perspective. Qualitative 
research methods were used to obtain a self-reported account of the experience of living 
with OMD. Eight individuals with OMD and dysarthria participated in face-to-face 
phenomenological interviews. Interviews were transcribed from audio recordings and 
coded using coding software. The codes were then grouped into larger thematic 
categories based on salience. Results showed that communicative participation is affected 
by multiple physical, social, and emotional factors caused by OMD. Furthermore, OMD 
can have significant effects on an individual’s job, family, and social life. Lastly, 
strategies and coping mechanisms used by participants were explored. This study will 
add to very sparse literature on OMD and will help to reveal the complexity of living 
with this disorder.  
 
Keywords: oromandibular dystonia, communicative participation, motor speech 
disorders, phenomenology, dysarthria, hyperkinetic dysarthria 
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Chapter 1 
1 Introduction 
1.1 Dystonia 
  Dystonia belongs to a category of neurological movement disorders 
characterized by random and unpredictable movements that can vary in speed, duration, 
and amplitude. These movements may be present at rest, during sustained postures, or 
during activity (Brin & Comella, 2004; Duffy, 2013). These dystonic movements usually 
stop during sleep and are exacerbated by stress and heightened emotion (Duffy, 2013; 
Scott, 2000). Dystonic movements range from mild to severe, and may be strong enough 
to interrupt or alter the direction of intended movement (Duffy, 2013; Tarsy & Simon, 
2006). Dystonia results from excessive co-contraction of agonist and antagonist muscles 
(Tarsy & Simon, 2006). Abnormalities appear to stem from impairment of the basal 
ganglia, cerebellum, and dopaminergic system (Duffy, 2013; Lee, 2007). 
Dystonia may be either primary or secondary. Dystonia is classified as primary if 
it occurs in the absence of other clinical symptoms, or if it is inherited. Dystonia is 
classified as secondary when it occurs in association with another known disease (Scott, 
2000; Tarsy & Simon, 2006). Dystonia can develop at any point in an individual’s 
lifetime, and can be classified as either early onset or late onset. Early onset dystonia 
occurs in childhood, before the age of 20. Late onset dystonia occurs in adulthood, after 
the age of 20 (Defazio, Abbruzzese, Livrea, & Berardelli, 2004). Dystonia is most 
prevalent among older adults, with an average age of onset of 66 years, and it is more 
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common in females than males (Lee, 2007). Dystonia can be focal (affecting one body 
region), segmental (affecting more than one adjacent body region), multifocal (affecting 
more than one non-adjacent body region), hemi-focal (affecting the muscles of only one 
side of the body), or generalized (affecting multiple muscle regions throughout the body) 
(Brin, & Comella, 2004). 
1.2 Oromandibular Dystonia  
Oromandibular dystonia (OMD) is a type of focal dystonia affecting the muscles 
of the lips, tongue, and/or jaw, which can impact speech production (Duffy, 2013). It is 
characterized by involuntary, repetitive, sustained, and sometimes painful muscle 
contractions (Clark, 2003; Duffy, 2013). There are six types of OMD: jaw closing 
dystonia, jaw opening dystonia, jaw deviation dystonia, lip dystonia, lingual dystonia, or 
a combination of any of these. When OMD occurs with blepharospasm (involuntary 
contractions of the eyelids) it is called Meige’s syndrome (Cardoso & Jankovic, 1995).  
For intended movements, muscle contraction may be disproportionate, or contraction 
may spread to muscles not normally involved. Secondary contractions may also impede 
the action of the primary muscles (Cardoso & Jankovic, 1995). OMD may cause 
difficulties with the opening and/or closing of the jaw, speech, and/or chewing and 
swallowing. Facial grimacing, lip pursing or retraction, and protrusion or rotary 
movements of the tongue may be present (Duffy, 2013). The oral mechanism is often 
normal in size, strength, and symmetry, and pathologic reflexes are usually absent 
(Duffy, 2013). Patients commonly present with drooling and dysphagia, and complain of 
food sticking in the throat or difficulty chewing (Duffy, 2013; Tarsy & Simon, 2006).  
  
3 
1.3 Pathophysiology of OMD 
As in many neurological conditions, the exact cause of OMD is largely unknown. 
OMD appears to reflect problems with sensorimotor integration, and so permits 
inferences about the role of the basal ganglia control circuit, specifically the putamen, 
cerebellum, and dopaminergic system (Duffy, 2013; Papapetropoulos & Singer, 2006; 
Tarsy & Simon, 2006). Impulses from the basal ganglia have an inhibitory effect on the 
thalamus, impeding cortical neuronal firing. Hyperkinetic disorders, such as dystonia, 
result from the absence of physiological inhibitory control of the basal ganglia over the 
cortical neuronal firing of the thalamus and brain stem (Duffy, 2013; Papapetropoulos & 
Singer, 2006). Structural imaging techniques of muscles affected by dystonia have shown 
a pattern of involuntary rapid firing of fibres, unlike normal firing of muscle electrical 
activity (Papapetropoulos & Singer, 2006).  
Causes of OMD may include trauma to the head and central nervous system, 
diencephalitic stroke, or neurodegenerative disorders such as Parkinson’s disease, 
multiple sclerosis, or Huntington’s disease. (Dworkin, 1996; Lai & Jankovic, 1998; 
Tinter & Jankovic, 2002). Drug-induced dystonia may be caused by levodopa, dopamine 
agonists, antipsychotic drugs, anticonvulsant agents, serotonin-reuptake inhibitors, and 
rarely by other miscellaneous drugs (Tarsy & Simon, 2006). Exposure to certain 
chemicals such as manganese, carbon monoxide, or carbon disulfide may also result in 
dystonia (Tarsy & Simon, 2006). There is evidence to suggest a genetic component in the 
appearance of OMD. Genes DYT1 through DYT13 have been associated with dystonia 
(Klein & Ozelius, 2002; Tarsy & Simon, 2006). These genes include autosomal 
dominant, autosomal recessive and X-linked causes of primary and secondary dystonia 
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(Tarsy & Simon, 2006). Specifically, DYT6, DYT7, and DYT13 have been linked to 
incompletely penetrant, autosomal dominant focal dystonias (Tarsy & Simon, 2006). 
Occasionally mutations in the torsin A gene at the DYT1 locus have also been identified 
in patients with adult-onset focal dystonia (Tarsy & Simon, 2006). In some cases, there 
may be a family history of dystonia (Tarsy & Simon, 2006). 
1.4 Epidemiology of OMD 
OMD is a rare condition, and the exact number of cases is largely unknown. 
Many general physicians are unfamiliar with dystonia, and as a result many cases are 
undiagnosed or misdiagnosed. Patients often have to consult several physicians before 
their dystonia is correctly identified (Tarsy & Simon, 2006). Common misdiagnoses 
include temporomandibular joint syndrome, myasthenia gravis, dental malocclusion, and 
edentulous movements (Tarsy & Simon, 2006). The estimated prevalence of OMD is 
68.9 cases/million persons (Nutt, Muenter, Aronson, Kurland, & Melton, 1988). 
Comparatively, the prevalence of all focal dystonias is approximately 300 cases/million 
persons (Brin & Comella, 2004). The estimated incidence of OMD is 3.3 cases/million 
persons (Nutt et al., 1988).  
1.5 Clinical Features of OMD 
The involuntary spasms associated with OMD can have devastating consequences 
on the daily functioning of those affected. OMD most commonly causes involuntary 
clenching, opening, or deviation of the jaw, with muscles of the mouth, tongue, or neck 
also frequently involved (Tarsy & Simon, 2006). The altered orofacial aesthetics 
associated with OMD, such as jaw deviation and involuntary tongue protrusions, can lead 
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to feelings of embarrassment and reduced self-confidence (Lee, 2007). OMD has been 
linked to depression and a reduction in quality of life (Bakke, Larsen, Dalager, and 
Moller, 2013). Severe cases may cause jaw pain, difficulty chewing, dysphagia, and 
dental trauma (Tarsy & Simon, 2006).  
A study by Papapetropoulos and Singer (2006) found that dystonic eating 
dysfunction may complicate OMD leading to weight loss. In a cohort of 53 patients with 
primary and secondary OMD, there was a 15.6% prevalence of eating dysfunction. Over 
half of the patients with eating dysfunction also reported significant weight loss. Eating 
dysfunction associated with OMD may include pain during eating and further social 
embarrassment when accompanied by drooling or choking (Papapetropoulos & Singer, 
2006). OMD may also cause oral trauma. Jaw-closing dystonia most often results in 
trauma, consisting of persistent grinding of the teeth or biting of the tongue, wearing of 
the enamel or early loss of teeth, trauma of the lips or gums, or persistent jaw pain 
(Bakke et al., 2013). Dystonic activity may also cause head and jaw pain, muscular 
tension or tiredness, and a reduced salivary flow rate (Bakke et al., 2013). Involuntary 
closing of the jaw may produce inappropriate deviation of the mandible, partial 
dislocation, intramural soft tissue trauma, and bone resorption (Gandhi, 2010).  
In addition to altered orofacial esthetics, orofacial pain, difficulty with chewing, 
and dental trauma, OMD can also result in a communication disorder called dysarthria. 
Dysarthria is a collective name for a group of neurologic speech disorders that reflect 
abnormalities in the strength, speed, range, steadiness, tone or accuracy of movements 
required for the respiratory, phonatory, resonatory, articulatory, or prosodic aspects of 
speech production (Darley, Aronson, & Brown, 1969b; Duffy, 2013). According to 
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Enderby and Emerson (1996), dysarthria is the most commonly acquired disorder of 
communication. Darley, Aronson, and Brown (1969a, 1969b) created a perceptual 
classification scheme of dysarthria based on the location of lesion and associated deviant 
speech dimensions. Following this classification, dystonia is a hyperkinetic dysarthria 
and an impairment of the extrapyramidal system. Unlike other dysarthrias based on the 
central nervous system, hyperkinetic dysarthria can result from abnormal movements at 
only one level of the speech system, for example articulation, or a few muscles at that 
level, for example the muscles of the lips (Duffy, 2013). Hyperkinetic dysarthria accounts 
for 19% of motor speech disorders according to evaluations among 8101 people studied 
at the Mayo clinic from 1993 through 2008 (Duffy, 2013).  
Darley et al. (1969b) presumed the neuromuscular deficits associated with the 
dysarthria of dystonia to cause slow, involuntary movements, with irregular rhythm, 
reduced range, and excessive tone. Darley et al. (1969b) found the most deviant speech 
dimensions of dystonia to be: imprecise consonant articulation, vowel distortion, harsh 
voice quality, irregular articulatory breakdown, strained-strangled voice quality, 
monopitch, monoloudness, vocal tremor, alternating loudness, and voice stoppages. In 
this original classification of dystonia, spasmodic dysphonia (hyperadduction of abductor 
or adductor laryngeal muscles) was included in the description of dystonia. Therefore, the 
laryngeal impairments described by Darley et al. (1969b) in the description of dystonia 
such as a harsh voice, strained-strangled vocal quality, voice stoppages, and vocal tremor, 
should not be included in the perceptual features of the dysarthria associated with OMD.  
1.6 Speech Intelligibility 
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The hyperkinetic dysarthria associated with OMD can result in reductions in 
speech intelligibility (Dykstra, Adams, & Jog, 2007). Speech intelligibility is defined by 
Yorkston, Strand and Kennedy (1996) as the “degree to which the acoustic signal is 
understood by the listener” (p. 55). More broadly, speech intelligibility can be viewed as 
the “understandability of speech” (Kent, 1992; Yorkston, Dowden, & Beukelman, 1992). 
For individuals experiencing OMD, involuntary muscle spasms of orofacial musculature 
may affect the understandability of their speech. Weismer, Yunusova and Bunton (2012) 
suggest that the tongue is the most influential articulator in speech intelligibility. 
Weismer and colleagues also assert that tongue control may be more strongly related to 
speech intelligibility in individuals with neuromotor pathology than lip/jaw control. 
Assessing speech intelligibility allows researchers and clinicians to categorize dysarthria 
by severity level, provides a quantitative way to monitor speaker performance during the 
course of treatment and recovery, and creates a universal way to relay progress amongst 
other clinicians, to the speaker, or to his/her family members (Yorkston & Beukelman, 
1978).  
1.7 Treatment of OMD 
Since there is no known cure for OMD, clinical focus is placed on various 
treatments and strategies for reducing dystonic symptoms and improving quality of life.  
Pharmacological.  Pharmacologic agents used to treat OMD include: 
anticholinergics (e.g. trihexyphenidyl, benztropine), benzodiazepines (e.g. clonazepam, 
lorazepam, diazepam), baclofen, and tetrabenazine, which deplete dopamine and block 
dopamine receptors (Tintner, & Jankovic, 2002). Although these drugs have been found 
useful in some patients, it is not the preferred form of treatment for focal dystonias since 
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there is only modest improvement and frequent side effects (Tintner, & Jankovic, 2002). 
Medications are most effective in cases of widespread dystonia. One of the most well 
tolerated medications for treating OMD is clozapine, a dibenzoadiazepine that differs 
from conventional neuroleptics in its interactions with neurotransmitter receptors and in 
its range of side effects (Karp, Goldstein, & Chen, 1999). The pathophysiology of 
dystonia is thought to involve dysfunction of dopaminergic pathways in the basal ganglia. 
Clozapine acts on the dopaminergic pathways by binding to, and increasing, D1 
dopamine receptor density in the basal ganglia, which reduces the over-activity of the 
direct pathway (Karp et al., 1999).  
 Sensory.  A sensory trick, or geste antagoniste, is a method some patients with 
OMD use to temporarily relieve their dystonic symptoms (Duffy, 2013). A sensory trick 
can include such acts as holding an object in the mouth, chewing gum, or touching a 
certain area of the face, such as the chin, cheek, or eyelid. Sensory tricks may help 
patients to speak and chew. The mechanism behind sensory tricks is unknown (Duffy, 
2013).  
 Prosthetic.  Based on the premise of sensory tricks, various devices have been 
used in the treatment of OMD. A commonly used device for treating jaw or lingual types 
of dystonia is a bite-block. A bite-block is a device that is tailored to the individual 
patient, and placed between the upper and lower teeth to help with jaw stability and 
positioning. Bite-block therapy has been shown to improve facial appearance, articulatory 
precision, and hyperactive movements in hyperkinetic dysarthrias (Dworkin, 1996; 
Goldman & Comella, 2003). Dworkin (1996) found that insertion of a bite-block in two 
individuals with OMD secondary to Meige’s syndrome resulted in immediate conversion 
  
9 
from moderately reduced intelligibility to near normal speech intelligibility in both 
individuals. It was hypothesized that the bite-block neutralized dystonic activity by 
facilitating postural balance and motor stability of the mandible. A bite-block may 
prevent enamel wear, decrease the load on oromandibular joints, and improve chewing 
function (Blanchet, Rompre, Lavigne, & Lamarche, 2005). In addition to stabilizing the 
jaw and reducing dystonic movement, a bite-block may provide sensory information for 
the correct placement of other articulators (Lee, 2007). Although these techniques are not 
long-lasting, they are noninvasive and may aid other forms of therapy. 
 Botulinum toxin.  The most contemporary and well-tolerated method of 
treatment for OMD is localized injection of botulinum toxin into the affected muscles 
(Goldman & Comella, 2003; Munchau & Bhatia, 2000; Ramachandran & Molloy, 2012). 
Botulinum toxin is a protein produced by the anaerobic bacterium Clostridium botulinum 
(Simpson, 1981). There are seven immunologically distinct toxins, however only types 
A, B, and E have been used in humans. Botulinum toxin type A (BoNT-A) is the most 
effective type in the treatment of OMD (Kazerooni & Broadhead, 2015). BoNT-A causes 
temporary paralysis by blocking the presynaptic release of acetylcholine at the 
neuromuscular junction (Simpson, 1981). After binding to presynaptic cholinergic nerve 
terminals, BoNT-A decreases the frequency of acetylcholine release (Avila, Drachman, 
& Pastronk, 1989). Paralysis occurs within a few hours post-injection (Kao, Drachman, & 
Price, 1976). Within 2 days after injection, the axon terminal begins to sprout and form 
new synaptic contacts on the adjacent muscle fibers. For this reason, the effects of BoNT-
A are limited in duration. The effect of BoNT-A lasts 3 months on average, after which 
another injection is required (Simpson, 1989). 
  
10 
 Botulinum toxin was introduced as a therapeutic agent for OMD in 1977 (Blitzer 
& Sulica, 2001). The muscles most commonly implicated in jaw opening or closing 
dystonia are: the masseters, temporalis or internal pterygoids; the submental muscles or 
external pterygoids; and the genioglossus and hypoglossus muscles in tongue protrusion 
dystonia (Tintner & Jankovic, 2002). A variety of methods can be used to determine the 
proper injection sites. EMG may be used to monitor the muscles that show increased 
activity during the particular abnormal movement or posture (Tintner & Jankovic, 2002). 
In the case of OMD, it is difficult to determine all the muscles involved since EMG 
recordings are not completely accurate, and the pattern of muscle involvement may 
change over time (Tintner & Jankovic, 2002). For this reason, injection site and dose may 
vary for each appointment. Injection of BoNT-A into the masseter, temporalis, and lateral 
pterygoid muscles results in reduction of spasm, and improvement in chewing and 
speech, in approximately 70% of patients with OMD (Jankovic, Schwartz, & Donovan, 
1990). Side effects associated with BoNT-A include: weakness, mild dysarthria, and 
difficulty chewing and swallowing (Goldman & Comella, 2003).  
 There are currently three Food and Drug Administration approved BoNT-A 
products available: onabotulinumtoxinA (Botox®, Allergan), abobotulinumtoxinA 
(Dysport®, Ipsen Biopharmaceuticals), and incobotulinumtoxinA (Xeomin®, Merz 
Pharmaceuticals) (Kazerooni & Broadhead, 2015). A cost-utility analysis found that 
Xeomin® was the most cost-effective BoNT-A product compared to Botox® and 
Dysport® (Kazerooni & Broadhead, 2015). Botox® for non-cosmetic use is covered by 
most health insurance plans. 
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Behavioural.  Behavioral techniques can be a useful addition to any of the above 
treatments of OMD. Speech-language pathologists (SLPs) focus on providing behavioral 
therapy to improve the coordination of articulators (Goldman & Comella, 2003). SLPs 
may also provide management of masticatory and swallowing capabilities (Goldman & 
Comella, 2003; Duffy, 2013). An SLP may also suggest dyadic strategies to improve 
communication between the speaker and his or her communication partners. Strategies 
can include: getting the listener’s attention before speaking, making the context and topic 
clear, maintaining eye contact, using gestures whenever possible, and modifying the 
communicative environment to improve visual and auditory acuity (Duffy, 2013). 
Listeners can also play a supporting role by listening attentively and actively to the 
speaker, and informing the speaker immediately of any misunderstandings (Duffy, 2013).  
Unfortunately, little attention has been given to the impact of these various 
treatment approaches on speech intelligibility. There is a small empirical literature 
suggesting improvements to articulatory precision following the use of a bite-block 
(Dworkin, 1996), and there is preliminary evidence suggesting that, depending on the 
type and location of OMD, there may be an improvement to speech intelligibility 
following BoNT-A injections (Dykstra et al., 2007; Dykstra, Domingo, Adams & Jog, 
2015). It is unfortunate that there is such a small empirical literature on speech 
intelligibility in this clinical population since dysarthria is often a disabling feature of 
OMD and has the potential to result in psychosocial consequences such as reductions in 
communicative participation. 
1.8 Communicative Participation  
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The characteristics of OMD can be further organized according to the World 
Health Organization’s International Classification of Functioning, Disability, and Health 
(ICF) (WHO, 2001). The ICF provides a conceptual framework of disability from a 
biopsychosocial perspective. The ICF asserts “Health is a state of complete physical, 
mental and social well-being, and not merely the absence of disease or infirmity” (WHO, 
2001). The ICF defines ‘impairment’ as a ‘problem in body function or structure,’ 
‘activity’ as the ‘execution of a task or action by an individual,’ and ‘participation’ as 
‘involvement in life situations’ (WHO, 2001). Eadie, Yorkston, Klasner, Dudgeon, Dietz, 
Baylor, Miller, and Amtmann (2006) extended the ICF definition of participation to 
communication by defining ‘communicative participation’ as ‘taking part in life 
situations where knowledge, information, ideas or feelings are exchanged’. 
Communicative participation encompasses many life situations including: personal care, 
household management, leisure, learning, employment, relationships, and community life 
(Eadie et al., 2006; Yorkston, Baylor, Dietz, Dudgeon, Eadie, Miller, & Amtmann, 2008).  
The ICF model also includes environmental (external) and personal (internal) 
contextual factors that contribute to the consequences of a health condition. Historically, 
clinical focus has taken an impairment-based perspective to treating communication 
disorders (Eadie, 2001; Threats, 2000). This is probably because it is easier to measure 
biomedical aspects, such as physiological functioning, rather than psychosocial aspects of 
health. Recently, there has been a shift in attention to the psychosocial aspects of health 
across the field of healthcare in general as well as in the field of communication 
disorders.  
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Garcia, Laroche, and Barrette (2002) explored barriers to work integration for 
individuals with a variety of communication disorders, including those with dysarthria.  
Findings of this study showed many barriers to employment as a result of these 
communication disorders, such as the attitudes of communication partners, noise level, 
phone use, group discussions, and the need for rapid communication. Baylor, Burns, 
Eadie, Britton, and Yorkston (2011) examined self-reported communicative participation 
in everyday speaking situations across a wide range of communication disorders 
including spasmodic dysphonia (SD), stroke, multiple sclerosis (MS), Parkinson’s disease 
(PD), laryngectomy, amyotrophic lateral sclerosis (ALS), and stuttering. Participants 
described many functional and emotional interferences to communicative participation, 
including difficulty maintaining adequate loudness, lack of expressiveness, imprecise 
articulation, difficulty keeping up with conversations, and difficulty speaking in noise 
and on the phone. Participants also reported using various strategies to improve their 
intelligibility, including speaking louder, simplifying speech, using different modalities, 
relying on family and friends, and educating others.  
Baylor, Yorkston, and Eadie (2005) took a qualitative approach to explore the 
biopsychosocial consequences of spasmodic dysphonia (SD). Six adults with SD 
participated in face-to-face phenomenological interviews. The results of this qualitative 
study created a model of personal experiences of SD that suggested that communication-
related quality of life is shaped by experiences with multiple physiologic, personal, and 
social factors. For example, participants reported feeling self-conscious, embarrassed, 
frustrated, less intelligent, less confident, and less competent (Baylor et al., 2005). The 
attitudes and reactions of other people contributed to these feelings and restricted 
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participation. Participants stated that comments were often made towards them about 
their lack of ability based on the sound of their voice. They felt that with the onset of 
their disorder, they were suddenly viewed as unskilled or unintelligent, when they were 
actually quite capable and qualified. Participants felt that aside from their close families 
and friends, people did not understand their disorder, and lacked the patience to 
communicate with them. Unfamiliar people were quick to make false judgments, and 
were less accommodating of communication difficulties. Participants adopted strategies 
such as planning ahead, avoiding difficult situations, and maintaining a good attitude.  
Research in the area of neurological speech disorders has also focused on the 
perception of the self as a communicator. Walshe, Miller, Leahy, and Murray (2008) 
examined speaker self-perception in a group of 20 people with acquired dysarthria. 
Speakers self-rated their own speech intelligibility using direct magnitude estimation. 
These ratings were then compared to intelligibility scores on the Assessment of 
Intelligibility of Dysarthric Speech (AIDS) (1981). Results showed no correlation 
between speakers’ perceptions of intelligibility and severity ratings on the AIDS. This 
suggests that speakers view their speech differently than listeners. A proposed 
explanation is that speakers may rate their intelligibility generally, while listeners rate 
articulation of specific sentences (Walshe et. al, 2008). Miller, Noble, Jones, Allcock, and 
Burn (2008) examined how self-perceived communication changes over time in a cross-
sectional survey of 104 people with PD. Participants with PD completed a semantic 
differential questionnaire comprised of bipolar adjectives or statements representing key 
variables in the domain of communication disorders. Across all participants, there was a 
statistically significant perception of deterioration in communication after the onset of 
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PD. People with PD reported a loss of control in communicating, less confidence 
communicating, difficulties getting their message across, and feelings of frustration, 
inadequacy, and a sense of lost independence (Miller, Noble, Jones, & Burn, 2006). In a 
follow-up longitudinal study, Miller, Andrew, Noble, and Walshe (2011) administered a 
semantic differential questionnaire to 31 people with PD at 3 different time points: in the 
early stages of PD, and at two later assessment points 3 years apart. The results of this 
study showed negative changes in perception of self as a communicator in areas 
involving competence, adequacy, control, and ease of communication.  
Measuring communicative participation.  Communicative participation is 
measured in a social context, in which there is an exchange of information and ideas 
between more than one person (Eadie et al., 2006). Baylor, Yorkston, and colleagues 
developed a validated tool to measure communicative participation, called the 
Communicative Participation Item Bank (CPIB) (Baylor, Yorkston, Eadie, Kim, Chung, 
& Amtmann, 2013; Baylor, Yorkston, Eadie, Miller, & Amtmann, 2009; Yorkston, 
Baylor, Dietz, Dudgeon, Eadie, Miller, and Amtmann, 2008). The aim of this measure is 
to better understand how communication disorders impact communication in real life 
situations. Measuring communicative participation is important because it advances our 
understanding of both the impact of disablement and the contextual factors that affect it, 
and helps to develop and revise models of intervention (Eadie et al., 2006). 
Unfortunately, the literature regarding the effect OMD has on communicative 
participation is sparse. Prior to the development of the CPIB, Dykstra, Adams, and Jog 
(2007) investigated the perception of activity and participation restrictions in an 
individual with lingual dystonia receiving therapeutic BoNT-A injections. A subjective 
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evaluation was obtained by administering a modified version of the Voice Activity and 
Participation Profile (VAPP) pre- and post- BoNT-A treatment. The VAPP is a 28-item 
self-assessment questionnaire developed to evaluate perceptions of speech problems, 
activity limitations, and participation restrictions (Ma & Yiu, 2001). Examination of the 
VAPP revealed dramatic changes on all domains measured by the questionnaire 
following treatment, such as self-perceived severity of the speech problem, effects on job, 
and daily social communication and emotion. Results also showed a dramatic change in 
self-rated activity limitation and participation limitation pre- and post- treatment. 
Specifically, there was a significant positive difference in the direction of scores 
following treatment. These results highlight the importance of examining the impact of a 
speech disorder on an individual’s daily functions in the context of their personal, social, 
and environmental situation (Dykstra et al., 2007; Ma & Yiu, 2001).  
 One component of communicative participation is communicative effectiveness. 
Communicative effectiveness is described as a person’s ability to successfully 
communicate their message in home and community settings (Hustad, 1999). 
Communicative effectiveness can be measured using the Communicative Effectiveness 
Survey (CES). The CES is comprised of eight items rated on a four-point scale (Hustad, 
1999). The CES allows speakers with dysarthria and their communication partners to rate 
communicative effectiveness in various life situations in order to identify which 
situations are perceived as most difficult (Hustad, 1999). Ball, Beukelman, and Pattee 
(2004) used the CES to measure the communicative effectiveness of 25 people with 
amyotrophic lateral sclerosis (ALS) and resulting dysarthria. The CES was administered 
to both the participants with ALS and their communication partners, separately. The 
  
17 
results of this study found that speakers and listeners reported similar perceptions of 
communicative effectiveness, and self-rated communicative effectiveness was positively 
related to speech intelligibility. Donovan, Kendall, Young, and Rosenbek (2008) 
examined communicative effectiveness in individuals with PD and their significant 
others. In contrast, the results of this study found that participants with PD rated 
themselves with significantly higher ratings of communicative effectiveness than their 
significant others, and speech intelligibility was not a significant predictor of 
communicative effectiveness. McAuliffe, Carpenter, and Moran (2010) examined the 
differences in perceived communicative effectiveness between eight participants with 
dysarthria following traumatic brain injury (TBI) and their communication partners. 
Results showed a trend for participants with TBI to rate their communicative 
effectiveness higher than their communication partners, but this finding was not 
significant. Furthermore, there was no relationship between communicative effectiveness 
and intelligibility. Dykstra, Domingo, Adams, and Jog (2015) administered the CES to 
participants with OMD receiving therapeutic BoNT-A, and to healthy control 
participants. The results of this study showed a significant difference between OMD and 
control participants’ overall ratings of communicative effectiveness. More specifically, 
there were significant differences between OMD and control participants on five out of 
eight items on the CES. The items on the CES with the largest effect size were 
“conversing with a stranger on the telephone” and “having a conversation with a family 
member at home”. These items accounted for 66.4% and 49% of the variance between 
OMD and control participants, respectively. These results suggest that individuals with 
OMD self-report significant reductions in communicative effectiveness relative to control 
  
18 
participants. Furthermore, the results of this study provide insight into the everyday 
consequences of OMD. This preliminary work by Dykstra et al. (2015) provides a 
rationale for exploring communicative participation in this clinical population in more 
depth.  
The experience of a speech disorder is highly individualized, and dependent on a 
wide array of personal, contextual, and environmental factors. Furthermore, the 
psychosocial impact of impaired communication does not necessarily correlate strongly 
with any clinical measurement (Walshe & Miller, 2011). This can make it a difficult 
phenomenon to capture in research. Qualitative research methods are ideally suited for 
studying the complex nature of speech disorders because they identify the individual with 
the disability as the “expert,” rather than the researcher or clinician (Dowling, 2007). A 
qualitative approach provides space for “participant voice,” which allows for a genuine 
account of the insider’s experience. Participants share with the researcher the information 
and experiences that are of importance to them (Dowling, 2007). In qualitative research, 
participants are not restricted by rigid questionnaires and rating scales, nor are they 
influenced by any presuppositions held by healthcare professionals (Dowling, 2007). 
Previous research has taken a qualitative approach to study the experience of 
communication impairments within specific medical conditions (e.g. PD, motor neuron 
disease, multiple sclerosis, or stroke) revealing changes in relationships, social and 
emotional effects, and perception of stigmatization (Blaney & Lowe-Strong, 2009; 
Miller, Noble, Jones, Allcock, & Burn, 2008; Miller, Noble, Jones, & Burn, 2006; 
Yorkston, Klasner, & Swanson, 2001). However, there is currently limited research 
investigating the impact of OMD on communicative participation.  
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1.9 Rationale for Current Study 
The purpose of the current study was to obtain a self-reported account of the 
experience of living with OMD, and to gain a better understanding of both the daily 
facilitators and interferences to communicative participation specific to this cohort. The 
goal for this study is that by using qualitative research methods, this research will add 
novel information to the understanding of the consequences of OMD on communicative 
participation. By understanding the perspective of the insider, it is further anticipated that 
this information will help inform the clinical management of individuals with OMD and 
dysarthria.  
Chapter 2 
2 Method 
2.1 Participants 
 Eight participants diagnosed with OMD were recruited to participate in this 
study. In total there were five males and three females (age range: 44-80 years; mean age: 
68 years), with an average OMD onset of 10.4 years. Participants’ occupations, in no 
particular order, were: receptionist, ad exec, homemaker, teacher, self-employed, 
engineer, chief executive officer, and principal. Some participants were retired at the time 
this study was conducted. Participants were recruited from the Movement Disorders 
Clinic, London Health Sciences Centre at London, Ontario and were seen by neurologist 
Dr. Mandar Jog. Participants with OMD were reported to demonstrate hyperkinetic 
dysarthria by a Speech-Language pathologist (A.D.) and a Neurologist (M.J.) specializing 
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in movement disorders. The presence of hyperkinetic dysarthria associated with OMD 
was the primary inclusion criterion of this study. Additional inclusion criteria included: 
(1) all participants with OMD had no prior history of speech, language, or hearing 
problems (except those related to OMD); (2) all participants were required to read, speak, 
and understand English; (3) recruitment was limited to an age range of 25 to 80 years. 
This age range was chosen to represent a wide range of the adult population and to 
capture the average age of onset of OMD (66 years; range of 40 – 80 years); (4) all 
participants were receiving botulinum toxin injections to manage symptoms of OMD; (5) 
individuals with any type of OMD (i.e., lingual, jaw-opening, jaw-closing, mixed) were 
eligible to participate in the study. Table 1 contains specific data for each participant. 
This table includes information about the participants’ sex, age, disease duration, type of 
OMD, and occupation.  
Table 1. Demographic information of participants with OMD 
 
Participant 
ID 
Sex Age 
(years) 
Years 
since 
diagnosis 
Years 
receiving 
Botox 
Type of OMD 
GM M 69 4 3 Meige’s (jaw closure, lingual) 
ST F 78 2 3 months Jaw opening 
NF F 60 10 8 Lingual 
JR M 44 2 3 months Meige’s (pouting, jaw closure) 
FI F 69 21 21 Jaw closure 
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SP M 78 13 11 Lingual, jaw closure 
EP M 80 23 22 Meige’s (jaw opening, closure) 
BR M 68 8 3 Jaw closure 
 
 
The researcher explained the nature of the study as well as provided each 
participant with a letter of information (Appendix A) and a consent form (Appendix B) to 
sign prior to participating in the study. This study was approved by the Health Sciences 
Research Ethics Board at Western University (Appendix C). 
2.2 Research Approach  
The current study was conducted using a qualitative phenomenological approach. 
Phenomenology is a method of inquiry that allows for the exploration of the experiences 
of a group of people who share a common phenomenon (Dowling, 2007). In this case, the 
common phenomenon is the experience of living with OMD. Phenomenological research 
is based on the principle of lived experiences, which are the events that naturally occur in 
the lives of a specific cohort (Dowling, 2007). Phenomenology has become an 
increasingly popular research method in the health care field, as it takes the patient’s 
voice into primary account allowing for findings to emerge that may have not been 
previously explored (Dowling, 2007). Qualitative research creates a unique relationship 
between participant and researcher. Rather than attempting to remove the role of the 
researcher altogether, as is the case in quantitative research, qualitative researchers 
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attempt to interpret, to understand, and to describe information in a reflective process 
(Wilding & Whiteford, 2005). Furthermore, qualitative research adopts a subjectivist 
paradigm, meaning that reality is a subjective construct based on context and personal 
experience, rather than an absolute, as suggested in the positivist tradition (Wilding & 
Whiteford, 2005).    
2.3 Procedure 
Interviews.  Each participant attended one face-to-face interview. Interviews 
were conducted by the primary researcher in a private room. The primary researcher was 
not involved in the clinical care of the participants. Interviews lasted between one and 
one-and-a-half hours, and were audio recorded for later transcription. Since participants 
had reduced speech intelligibility due to dysarthria, interviews were scheduled at 5 weeks 
post-BoNT-A injections to correspond to the peak effectiveness of BoNT-A treatment. 
All participants presented with speech intelligibility that was reduced but understandable 
to the interviewer. If the researcher did not understand a word or sentence spoken by a 
participant during the interview, she asked for clarification and repetition to ensure 
correct understanding and meaning. 
Phenomenological interviews were guided by the participant to the topics that 
she/he found relevant. This differs from quantitative research methods, which are guided 
largely by pre-determined questions. It is expected that phenomenological interviews will 
produce a detailed account of the experience of living with OMD, in the words of the 
persons who live it. 
  Interviews were guided by four general questions: 
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1) Tell me about your history with OMD, for example when did your symptoms start 
and how did that affect you? 
 2) What impact has dystonia had on your life?  
From there, the researcher encouraged participants to talk about their experiences and 
feelings, and to provide stories or anecdotes. The researcher asked additional questions as 
needed to clarify points or to seek additional information. These questions included: 
i) Has your job been affected by OMD? If yes, how? 
ii) Has dystonia impacted your role in the family?  
iii) Has dystonia impacted your household duties or responsibilities?  
iv) Has dystonia impacted you emotionally? 
v) Has dystonia impacted your day-to-day communication?  
vi) Has dystonia changed your participation in any social activities?  
3) What is communication like for you? 
Follow-up questions included: 
i) Are there any situations or contexts that you find better or worse? 
ii) Do you do anything that is helpful in improving your speech? 
iii) What worked well? What went wrong? 
4) Are there times when people don’t understand you? 
Follow-up questions included: 
i) If yes, what specific contexts/environments/situations were easy versus 
difficult? 
Interview analysis.  Interviews were transcribed verbatim from audio recordings 
by a secondary researcher. Interviews were analysed following qualitative guidelines 
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(Benner, 1994; Creswell, 1998; Dowling, 2007). First, interviews were read multiple 
times for familiarity. Then the research team created a set of codes based on the content 
of the interviews. Codes provide a way of organizing the content of the transcripts into 
topic areas. Codes were developed in an iterative manner via multiple readings of the 
interviews and discussions among the research team. Once a final code dictionary had 
been developed, Dedoose software (Dedoose Version 6.1.18, 2015) was used to assign 
meaningful codes to excerpts of the transcripts based on subject matter, and then to index 
and sort these excerpts. An example excerpt was: “I probably felt sorry for myself, and a 
little bit depressed, and frustrated learning to deal with [OMD]. Working around different 
scenarios and different life situations each day, it’s not fun.” (N.F.) This excerpt 
highlights the emotional consequences of OMD, and received the code “emotional 
reactions”. There were a total of 21 initial codes (Appendix D). After the interview 
transcripts were coded and sorted into their content areas, each of the content areas were 
read in detail and summarized for patterns that emerged. Themes were developed to 
reflect the most salient patterns within and across coded topic areas.  
The goals for the final qualitative analysis were to:  
1) identify commonalities and differences among participants’ experiences 
2) reflect the complexities and multiple realities among participants through 
descriptive accounts 
3) illustrate the themes through the language of the participants  
(Benner, 1994). 
2.4 Credibility 
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 Several steps were taken to promote the credibility of the data. Audio recordings 
were first transcribed by research assistants who were otherwise uninvolved in data 
collection and analysis. The secondary researcher then reviewed the transcripts and made 
any notations where there were discrepancies between what she heard on the recording 
and what the transcript contained. Discrepancies were resolved via consensus of the 
research team.  
 Interview analysis was conducted in an iterative manner by the research team 
consisting of individuals with varying backgrounds including doctoral training in 
qualitative methods, years of experience conducting research using the phenomenological 
approach, and experience treating OMD. Emerging interpretations of the data were 
reviewed and challenged by each member of the research team.  
2.5 Verifiability 
   In qualitative research, verifiability refers to the extent to which the findings are 
an authentic representation of the phenomena they are intended to portray (Anderson, 
2010). There are multiple techniques that can be used to verify qualitative research 
findings. This study used constant comparison to ensure rigour in the design. ‘Constant 
comparision’ means the emerging analyses were compared with previous ideas in an 
iterative and reciprocal manner ensuring that the data were viewed as a whole rather than 
in fragments (Anderson, 2010). For example, after each interview was coded, the 
researcher compared it with all previously coded interviews, and any necessary changes 
to coding were made. Similarly, after each code group (all quotes that received the code 
“X”) was analyzed, the researcher compared resulting interpretations to previous 
interpretations, and again findings were adjusted as needed, so on and so forth. Data 
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analysis followed in this reciprocal manner until all interviews were coded, analyzed, and 
interpretations of the data were made. Analyzing data in this manner ensured that 
findings were representative of the experiences of all the participants involved. 
Chapter 3 
3 Results 
 Three major themes and seven sub-themes emerged from the analysis of interview 
data (Table 2). The first theme, Speaking is different now, contained information about 
the physical effort required to speak with OMD. The three sub-themes under this 
category included what my speech is like, my environment matters, and I use strategies. 
The second major theme was My roles have changed. This theme addressed changes in 
participants’ everyday lives since their diagnosis and incorporated two sub-themes: things 
that are different, and why I’ve made changes. The third major theme was I accept it and 
move on. This theme focused on how participants were able to deal with living with 
OMD. The sub-themes under this category were things that help, and OMD has given me 
a different perspective. Each of these themes and sub-themes will be described in greater 
detail below with quotes from participants to demonstrate how these themes were derived 
from the interviews to describe the consequences of OMD. 
 
Table 2. Themes and sub-themes describing the consequences of living with OMD 
 
Themes Sub-themes Definitions 
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3.1 Theme 1: Speaking is Different Now  
 Participants described both internal and external factors that affected their speech 
production, including physical aspects of dystonia and environmental factors. Participants 
then described how they adapted their speech to improve their intelligibility.   
Speaking is different now 
 
 
What my speech is like  
 
My environment matters 
 
 
I use strategies  
 
 
Speech is effortful, quiet, slow, 
less intelligible   
Situational factors, i.e., eating, 
fast-moving/group conversations, 
unfamiliar listeners, unplanned 
speech, background noise, phone 
conversations  
Strategies to improve ease of 
communication and intelligibility 
i.e., using easier words, using 
shorter, less complex sentences, 
slowing rate of speech, increasing 
loudness, have others speak for 
me 
My roles have changed  Things that are different  
 
 
 
Why I’ve made changes  
 
Job status, from care-giver to 
care-receiver, household 
management, change in social 
activities  
Fatigue, intelligibility deficits, 
appearance, reactions of others  
I accept it and move on  Things that help 
 
OMD has given me a 
different perspective 
 
Educating others, new activities, 
using humour 
 
Being thankful for other abilities, 
positive attitude 
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 What my speech is like. Participants described changes in their speech 
production such as increased physical effort, slowed rate of speech, and difficulty 
articulating certain speech sounds.  
 N.F. (all initials are fictitious) explained that when she first started having 
symptoms of OMD, her speech slowly became “slurred” and it was more difficult to 
speak. As her symptoms worsened, she explained, “There was a point of, you could still 
understand what I was saying but it was an effort. A big effort to be able to make it 
clear.” E.P. described his speech as: “...thicker and changed and slower; took more time 
to formulate the jaw, tongue, throat muscles to make the pronunciations that would 
normally roll off your lips prior to that.” S.P. similarly described trouble speaking 
because “the lips didn’t seem to want to make the sounds.” These examples highlight 
authentic patient experiences of effortful and impaired communication resulting from the 
dysarthria associated with dystonia such as slowed rate of speech, impaired articulation, 
and reduced speech intelligibility.  
 My environment matters. Participants highlighted external environmental 
factors that made speaking more difficult and/or less intelligible. One obstacle common 
to all participants was eating. Multiple participants expressed difficulty participating in 
conversations while focusing on eating safely, and some participants reported avoiding 
situations that involved eating while engaged in conversation. For example, F.I. 
explained, “Just thinking, oh gosh, you know? You invited people over, you have to talk 
or eat or both, for a whole evening, it’s a big stress for me.” Since many social situations 
involve food, this can be a significant barrier for individuals with OMD. In addition to 
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the difficulties of participating in conversations while eating, participants also described 
difficulty speaking in group conversations. G.M. stated: 
If there were three of us [in conversation],.. how can you just keep on 
participating in a conversation? I had a hard time to get in there in that 
conversation. A very hard time getting in. By the time I would try and get ready to 
say something, the other person’s talking. And so I was always kind of behind in 
getting into that conversation. 
Participants also reported unfamiliar listeners, noisy environments, and speaking over the 
phone as external factors that made speaking more difficult. Four out of eight participants 
reported difficulty speaking over the phone. For example, S.T. explained: 
Well I think there are times [others don’t understand me], but they don’t want to 
let on, and then I have to repeat it... But I can tell, and especially on the phone, I 
notice I have to repeat; that they don’t understand.  
S.T. explained that speaking in noise exacerbated her dystonic spasms. “I don’t talk if 
we’re out and it’s a big noise. I just don’t talk. It’s too hard. You have to talk too loud 
and my jaw just goes crazy.” 
 I use strategies.  Participants described the strategies they used to improve their 
speech intelligibility. B.R. explained, 
I have a little strategy. If I was talking to someone and I had a real problem, I find 
myself  choosing my words. Instead of saying, ‘well it’s a very overcast day’ I 
might say something like ‘it’s quite cloudy.’ Things that would be easy for me to 
say.  
E.P. also found that choosing his words more carefully helped. “The words I would 
normally use that are more than three or four syllables, I just can’t get it out. So I have to 
stay with shorter words that I can pronounce, and that sound clearer.” Other strategies 
participants used were increasing loudness and slowing rate of speech. E.P. explained, “If 
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it’s a bad period, then I just try that much more. The alternate ways. Usually I can bring 
my voice up and speak slower and use fewer words, and it will get more through.” 
3.2 Theme 2: My Roles Have Changed  
 The consequences of OMD extend beyond changes in speech production. 
Participants explained how OMD impacted their roles in the workplace and at home, as 
well as in social activities. Results varied among loss of roles, role restrictions, and role 
changes. Interferences extended to many common life situations, and resulted in 
emotional difficulties. 
 Things that are different. One area of the participants’ lives that that was 
significantly impacted by OMD was work. Two participants revealed having to leave 
their job as a result of OMD that they otherwise would have continued.  
I had been [working]... I tried to continue [working] until the end of June that 
year. I  had a lot of difficulty, during the speaking part... I found I was losing a lot 
of confidence trying to do it, you know? I’d find I was doing a lousy job, so I just 
decided to leave it. (F.I.) 
When talking about her job, N.F. said,  
My speech had deteriorated and I just finally had to leave [my job]. I’m a pretty 
tough person and I pushed it to the very end because I loved my job. Considering 
I like to work,  that’s a big impact because I’m not doing what I like the most in 
my daily life. 
 N.F. stated that she was off work for two years due to symptoms of OMD. She also 
explained the negative effects of job loss, such as financial worries: “My whole lifestyle 
was diminished. I mean I’m only getting 60 percent of my income, you know?” The 
participants with jobs who continued to work stated that OMD significantly interfered 
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with their productivity. Participants reported decreased confidence at work, taking more 
time than usual to complete tasks, and needing more help. For example, B.R. stated, 
“[OMD] was really affecting my job, because I probably spent 80% of my time on the 
phone, and I even got from my colleagues “pardon?”, “what?” It was kind of 
embarrassing at times, especially at work.”   
 In addition to occupational changes, participants explained how OMD affected 
their roles in the family and in the household. One participant (N.F.) with young children 
explained having to shift responsibility to other members of her family as a result of her 
diagnosis.   
A lot of those meetings, the bank etc., had to finally be done by my husband or 
children ... because I’m not communicating what the needs are. I could write a 
cheque, but if there was any discrepancy over anything in the family household 
that needed to be dealt with it’s usually through communication.  
N.F. further described feelings of hopelessness and guilt for not being able to carry on 
with her responsibilities, and also disclosed that her children expressed anger at having to 
take on more work around the household.  
 Many participants described a change in their social activities. S.T. stated that 
because of her dystonia she would “prefer to stay at home a lot of times.” She continued, 
“I avoid going out. As long as I’m at home, well I’m comfortable, there’s nobody 
around... I’d prefer to just, be alone.” F.I. explained that because of dystonia she 
preferred solo activities that were less “socially interactive” such as knitting or painting. 
J.R. explained that he used to go out and socialize with new people at least once a week. 
Because of dystonia, J.R. said: 
I like to watch movies at home. So I just stay home and watch movies in my own 
space.  [Sometimes, but not often, I’ll] invite my friend or my cousin. You know, 
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watch TV or play video games, stuff like that. They know me and know what 
happened. So I’m comfortable around them.  
OMD can therefore have a significant impact on the individual and their family. Reasons 
for these changes will be discussed in the next section.  
 Why I’ve made changes. Participants provided insight into why their roles 
changed as a result of OMD. One of the reasons was the inability to be understood by 
others. E.P. and F.I. provided examples of common life situations where they had trouble 
being understood by others: 
I was in Tim Hortons getting a coffee and I told [the employee], I said two black 
coffees medium size. And she looks at me and says, “What?” I knew she didn’t 
understand me. So I said, “Two black coffees medium size!” [yells] She jumps up 
in the air! Same thing happened over the meat counter at Wal-Mart. And I said, 
“A half pound of roast beef!” [yells]. I felt so bad for her... (E.P.) 
In F.I.’s situation, she was unable to successfully complete her task as a result of her 
speech.  
I took in the [roll of film] to be developed in Shoppers Drug Mart… So I am 
carrying the [roll of film] and I wanted to say, “I need to get this developed.”… I 
am trying to say this to him, and he says, “Well, I can’t help ya if you can’t speak, 
can I!” I thought, well “Okay, you’re right!” Actually. I just walked out.  
These examples highlight the difficulty some participants’ faced while trying to continue 
on with their regular activities and responsibilities.  
  Another reason for role changes was the emotional consequences associated with 
OMD, such as experiencing unsuccessful interactions. Participants identified affective 
reactions to OMD, including feeling self-conscious, worried, embarrassed, and overly 
aware. For example, J.R. explained,  
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I might not approach a woman that I probably would before. Because, I didn’t 
even know what, what to say. Because my voice is going to come out weird, and 
you’d be like “what is she going to think?” So I might not say anything. 
N.F. highlighted how the facial spasms associated with OMD resulted in feelings of 
worry and fixation. She explained, “I can feel the movements underneath coming through 
the jaw and through my lips and whatever. I don’t know. Are they looking at me? Can 
they see that it’s moving?” Participants explained that they sometimes chose to avoid 
difficult situations because of how they made them feel.  
 Lastly, the fatigue felt from prolonged periods of speech restricted the ability of 
some participants to participate in roles. For example, S.P. explained:  
And another thing I did notice was if I’m speaking for a while, like when I go to 
Bible study and the pastor asked me to read from the Scripture. And the longer I 
keep reading, the more difficult it is for me to enunciate the words. 
N.F. explained that the fatigue from having to speak all day contributed to her decision to 
leave her job. “...it would be noticeable by the end of the day that it was more difficult for 
me to speak things clearly, and I was fatigued.”  
3.3 Theme 3: I Accept It and Move On 
 The third major theme reflected how participants were able to carry on with their 
lives after being diagnosed with OMD. Participants explained strategies that they found 
useful including support from family and friends, educating others, alternative activities, 
and using humour. Participants also revealed changes in perspective.  
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 Things that help. Participants explained some strategies that were helpful for 
adapting to life with OMD. For example, N.F. explained that educating others about 
OMD and alternative modes of communication helped ease communication. 
When I was losing a lot of communication, and a lot of friends and people didn’t 
know how to speak [to me], or even figure out that there’s an alternative as well 
as I did. I was actually the one training everyone, “Well you’re going to have to 
do this...” They don’t have alternatives in communication really. 
Participants also discussed how finding fulfillment in new roles and skills helped them 
deal with some of their losses. For example, F.I. was able to find new work that made use 
of her non-speech skills. She explained,  
I decided I did enough [educating], and I got into the [computer work]. And I 
thought, “Oh this is wonderful! Because I don’t really have to speak, and I can 
still [work] and get paid for it.” 
Three out of eight participants explained that maintaining a sense of humour helped them 
deal with difficult situations. N.F. stated, “I tried not to lose my sense of humour to some 
degree. I had a few scenarios there, and you have to be able to laugh at yourself, so I 
think that helped me get through it as well.” 
 OMD has given me a different perspective. The participants unanimously 
reported that they came to accept OMD and “move on”. Four out of eight participants 
used the phrase “I just have to deal with it”. Participants also expressed that “it could be 
worse” or “it’s not life and death.”  E.P. disclosed, “I don’t feel that I’m a victim... I don’t 
want to sit and think about it, “Oh poor me I can’t do this!” and maybe some people 
maintain that way, but I just don’t.” Another example of perspective was the participants’ 
new-found appreciation for what they were still able to do. N.F. explained, “I could 
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physically do things, I could walk, I could breath, I could touch. I can do lots of things 
just not speak.” N.F. also disclosed that OMD made her a more perceptive person. 
“Discovering what a good listener is, was remarkable to me. I found a way to gain from 
that and become a good listener instead of a good speaker.” The ability to focus on the 
positive aspects of their lives was a meaningful and a useful strategy used by participants 
to aid in their acceptance of their diagnosis of OMD.  
 In summary of the results, participants reported changes in their speech 
production and identified some common environmental factors that interfered with 
communication. Strategies that improved communication were discussed. In addition to 
alterations in speech production, participants experienced changes to their work, social, 
and family lives. Participants also explained some strategies they used to deal with OMD, 
and expressed the ability to lead meaningful and fulfilling lives despite their diagnosis of 
OMD.    
Chapter 4 
4 Discussion 
 The purpose of this study was to better understand the consequences of living 
with OMD and dysarthria, and the functional, social, and emotional interferences to 
communicative participation it may cause. This was accomplished with a focus on patient 
self-report of experiences related to their OMD. This discussion will further explore the 
results from this study and how they relate to communicative participation as well as 
previous literature. Limitations, future directions and clinical implications will be 
presented.  
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4.1 Speech Production  
 From the phenomenological analysis of the data, three overarching themes 
emerged. The first theme, Speaking is different now, dealt with the effects of dysarthria 
resulting from OMD. Participants in this study reported alterations and reductions to 
speech intelligibility. This is consistent with the prior literature on dystonia. Darley, 
Aronson and Brown (1969) studied the effects of hyperkinetic dysarthria associated with 
dystonia on speech intelligibility and found speech dimensions such as imprecise 
consonant articulation, vowel distortion, and abnormal direction and rhythm of 
movement to contribute to a decrease in speech intelligibility. Dykstra, Adams, and Jog 
(2007) also found reduced speech intelligibility in an individual with lingual dystonia. In 
the current study, the main concerns reported by the participants were the increase in 
effort required to produce intelligible speech, and fatigue after speaking for prolonged 
periods of time. Participants described their speech production as being slurred, slow, and 
difficult to understand. Furthermore, participants reported external interferences to their 
speech such as speaking over the phone, fast-paced conversations, and noisy 
environments.  
 Participants explained how changes in speech production affected their 
communicative participation in everyday life. They reported unpredictability of when 
they may or may not be understood by others which resulted in less frequent 
communicative participation, especially in high-stress/unfamiliar situations. Baylor et al. 
(2005) also found “unreliability of the voice” to be a concern for participants with 
spasmodic dysphonia (SD), contributing to the avoidance of social situations. One of the 
most difficult real-life situations for participants in the current study was communicating 
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while eating a meal. Most participants spoke to how it was difficult for them to maintain 
a conversation while focusing on what they were eating and watching for choking and/or 
food spillage. This was a difficult adjustment to make for participants who previously 
enjoyed participating in social situations such as group conversations around the dinner 
table.  
 Participants further explained strategies they used to improve their intelligibility. 
The most commonly reported strategy was being vigilant with speech production and pre-
planning the types of words and sounds that were easier than others to produce. Many 
participants stated that they simplified their speech by using shorter, less complex words 
and sentences, and speaking slower and louder. Baylor, Burns, Eadie, Britton, and 
Yorkston (2011) found a similar phenomenon in their qualitative study of communicative 
participation across different communication disorders. Participants described planning 
speech carefully, simplifying sentences, and specifically avoiding words that were 
difficult to say as being a helpful communicative strategy. One participant referred to this 
strategy as “dumbing down” her speech. This information helps to illustrate the 
functional restrictions to communicative participation experienced by individuals with 
OMD and the resulting interferences to communicative participation they may cause. 
4.2 Roles  
 The second major theme, My roles have changed, identified participants’ 
occupational, familial, and social roles that were affected by OMD. The most significant 
role loss identified by participants was occupational. This is problematic as job loss is 
often associated with economic instability and emotional difficulties (Smith, Taylor, 
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Mendoza, Barkmeier, Lemke, & Hoffman, 1998). Of the five participants that were 
working at the time this study was conducted, two had to leave their jobs as a result of 
OMD. The participants that continued to work after the diagnosis of OMD revealed being 
less productive and needing to make changes to their job. Previous research also found a 
significant impact of disordered communication on work life, resulting in job 
modifications, avoidance of pursuing new job opportunities, or job loss (Baylor et. al., 
2005; Smith et. al., 1998). This phenomenon, termed ‘occupational deprivation’, often 
affects individuals who are born with or have acquired a chronic illness or disability 
(Christiansen & Townsend, 2004). Occupational deprivation refers to situations and 
conditions that exist outside of people, depriving them of important occupational 
opportunities beyond their immediate control (Christiansen & Townsend, 2004, p. 236). 
Some of these external conditions may include stereotyped perceptions, limited 
expectations, and physical/functional barriers to occupational environments. Previous 
narrative accounts from individuals with a disability have highlighted attitudes of others, 
as well as frustrations with the physical environment, as preventing them from living full 
and rewarding occupational lives. It is therefore important to change the general public’s 
stereotyped perceptions of people with disabilities by promoting awareness and 
education, as well as creating barrier-free environments with unrestricted access and the 
availability of assistive technology when needed (Christriansen & Townsend, 2004). 
 Other areas of participants’ lives that were affected by OMD were social and 
leisure activities. As a result of reduced intelligibility and perceived reactions of others, 
participants became more hesitant of socialization, and sometimes needed convincing 
from family and friends to attend social activities. In some cases, participants chose to 
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avoid social situations altogether. Participants explained a preference for spending more 
time alone, or with close family and friends, rather that socializing with new people. 
Baylor et al. (2005) also found changes in the social lives of individuals with SD, with 
participants stating that they found themselves “sitting in the background” at social 
activities instead of participating like they normally would.  
4.3 Coping Strategies  
 The third major theme, I accept it and move on, reflected how participants 
managed with the effects of OMD. There is currently limited research on the coping 
strategies of individuals with communication disorders. Epstein, Hirani, Stygall, and 
Newman (2009) explored coping mechanisms in individuals with muscle tension 
dysphonia (MTD) and adductor spasmodic dysphonia (ASD) by administering the Voice 
Disability Coping Questionnaire. In the Epstein et al. (2009) study, ‘coping’ was defined 
as ‘the individual’s cognitive and behavioural efforts to manage the stress of illness’. 
Individuals were found to be either ‘proactive’ by using strategies such as information 
seeking and social support to eliminate the stressor, or ‘avoidant’ by the use of denial and 
withdrawal. In the current study, all of the participants described being proactive with 
managing their disorder, emphasising the acceptance of their diagnosis and the need to 
“move on”. Coping strategies used by the participants included maintaining a positive 
attitude, using humour, educating others, and being thankful for their other skills (e.g., 
being a good listener). Similarly, Baylor et al. (2005) found that for individuals with SD, 
strategies such as educating family and friends about their disorder helped them to gain 
support and reduce unpleasant interactions with others. Participants also reported dealing 
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with their SD by adopting a positive attitude, and keeping their SD in perspective relative 
to other medical conditions.  
 Although participants expressed positive reactions of acceptance and resilience, it 
is important that this not detract from the significance of the negative experiences and 
themes that emerged throughout the participants’ narratives, such as those pertaining to 
loss, embarrassment, difficulty, and frustration.  
4.4 Limitations of the Current Study 
 This study employed qualitative methods to collect, analyse, and present 
important findings on the experience of living with OMD. Qualitative research in the 
field of health sciences allows for the collection of complex data relating to patient 
experience, and creates a unique space for participant voice. There are, however, 
accompanying drawbacks. Qualitative research is generally conducted on a smaller scale 
than quantitative research due to the time-consuming nature of data collection and 
interpretation. Our research team intended to enrol a larger sample (10-12 participants), 
but due to feasibility issues such as recruitment difficulties, the rare nature of OMD, and 
the time constraints and scope of a student project, we completed this study with a sample 
size of eight participants. Although common themes did emerge from the data, a larger 
sample may have been required to approach saturation, meaning that the collection of 
more data would not have lead to new information relating to the research question. For 
these reasons, the current study is intended to be preliminary as opposed to one that is 
pursuing saturation. A larger sample would have also increased diversity in self-reported 
experience and would have increased the potential to hear a variety of viewpoints. All 
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participants in this study were recruited from the Movement Disorders Clinic, London 
Health Sciences Centre in London, Ontario, which may have led to a uniform 
demographic.  
  Lastly, a primary method for verifiability in qualitative research is ‘respondent 
validation,’ which involves consulting with the participants post-analysis to ensure that 
the data truly reflect their own interpretations of their experiences. This allows 
participants to comment on and clarify any points of misinterpretation and verify the 
authenticity of the researchers’ summaries. Unfortunately, this practice was unable to be 
completed within the time frame of this paper, however participants will be contacted in 
the future to participate in brief follow-up visits.  
 4.5 Future Directions 
 The results of the present study provide a rationale on which to base future work 
in the area of OMD. The consequences of OMD are highly complex, having effects on an 
individual’s social, emotional, and physical functioning. Future studies with a larger 
sample that rely on qualitative methodologies such as interview analysis may help 
researchers to further capture the complexities of living with OMD. This study focused 
on the effects of OMD on communicative participation. An interesting next step may be 
to use a similar study design to explore other consequences of OMD, such as the 
experience of various methods of treatment. Currently, the most accepted method of 
treatment for OMD is BoNT-A injections. Research is currently underway using 
qualitative methods to examine the effects of botulinum toxin treatment on 
communicative participation in individuals with OMD. 
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 In some cases, themes relating to role shifts and social participation were 
dependent on demographic factors specific to the individual. An interesting future 
direction may be to sample a larger number of participants and explore various 
demographic factors such as employment status, number of dependents, and age. This 
information may help to tailor intervention to future patients with similar demographic 
profiles.  
 Lastly, the information presented in this study may help adapt questionnaires such 
as the Communicative Participation Item Bank (Baylor et al., 2009) to include 
information specific to the effects of OMD on communicative participation.  
4.6 Clinical Implications 
 Understanding the restrictions to communicative participation that affect 
individuals with OMD is extremely useful in order to improve rehabilitation efforts in the 
field of speech-language pathology. A benefit of employing qualitative methodologies to 
collect this information is the ability for participants to speak openly about their disorder 
without any preconceptions from the healthcare community. The results of this study 
highlighted specific sources of difficulty, strategies used, and areas of importance to 
individuals living with OMD, in their own words. By listening to our participants’ stories 
and experiences we were able to draw two main conclusions that have clinical 
importance.  
 The first is that the consequences of OMD extend beyond the speech impairment. 
There has been a shift in focus in healthcare and disability management from simply 
minimizing symptoms to improving social, emotional, functional, and cognitive aspects 
  
43 
of functioning as well. This concept was solidified by the World Health Organization’s 
(WHO) 2001 definition of health as “a state of complete physical, mental and social well-
being and not merely the absence of disease or infirmity.” It is now more widely accepted 
that poor physical or mental health is likely to have many consequences including 
restrictions on social roles and shifts in social relationships (Dijkers, Whiteneck, & El-
Jaroudi, 2000). From the analysis of our data, concepts relating to social interaction, role 
shifts, and affective responses emerged as salient to the participants. Speech difficulties 
were rarely presented from only the physical perspective, but more commonly referred to 
in the context of social communication. For example, some participants expressed worry 
that because they had difficulty producing speech, others might misinterpret the meaning 
of their words. Participants also highlighted contextual and environmental factors that 
restricted their communication such as fatigue, background noise, speaking over the 
phone, and speaking to unfamiliar listeners. 
 The second conclusion is that living with OMD is a unique experience that is 
dependent on demographic factors such as employment status or age. For example, an 
individual diagnosed with OMD with young children might seek out strategies to aid in 
household management and child rearing, whereas an older individual might be more 
worried about choking while eating and maintaining community involvement. This is 
consistent with the phenomenological framework of inquiry that supports the belief in the 
existence of not just one reality, but of “multiple realities.” According to this belief, there 
exists no one “truth” to be uncovered; instead each individual constructs his/her own 
reality based on his/her personal experiences (Denzin & Lincoln, 2000). The results of 
this study therefore, confirm the idea that the treatment of speech disorders, and OMD 
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specifically, must take social, emotional, and functional consequences into account as 
well as physical symptoms. Furthermore, a treatment plan should be tailored to each 
individual based on his/her personal concerns and goals.  
Chapter 5 
5 Summary and Conclusions  
 This study has presented a perspective of the consequences of OMD on 
communicative participation as experienced by the insider. The results of this study 
suggest that communicative participation is affected not only by the physical symptoms 
of OMD, but also by many significant social and emotional components. Changes to 
communicative participation can affect an individual’s job, family, and social life. Lastly, 
the consequences of OMD are unique to each individual based on their goals and 
lifestyle. 
 This study adds to the very minimal literature on OMD, and builds upon the small 
empirical literature on the consequences of living with OMD. The results of this study 
make a significant and a novel contribution to the literature due to the phenomenological 
research methodology used. Participants in this study were able to speak openly about 
their experience of OMD in the absence of a structured questionnaire or a narrow line of 
questioning. As a result, novel phenomena emerged that will aid in the understanding of 
the consequences of OMD for researchers, clinicians, family members, and even newly 
diagnosed patients.  
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 Although this study included a small number of participants, the overlap in theme 
content suggests that the main consequences of OMD on communicative participation 
were explored. Future studies may still benefit from a larger and more varied sample of 
participants to ensure theme saturation. Future directions may include a more in-depth 
analysis of the demographic factors involved in the experience of OMD and the effects of 
various methods of treatment on communicative participation. Once more research is 
conducted to solidify qualitative themes in this area, quantitative statistical analysis may 
be beneficial to augment findings.  
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Appendices 
Appendix A 
Letter of Information      
STUDY TITLE 
The effects botulinum toxin A on speech intelligibility, levels of speech usage, communication 
apprehension, self-perceived communication competence, communicative effectiveness, 
communication-related quality of life and the lived experiences of individuals with 
oromandibular dystonia. 
PRINCIPAL INVESTIGATOR 
Allyson Dykstra, Ph.D. 
Assistant Professor 
School of Communication Sciences and Disorders, Western University 
CO-INVESTIGATOR 
Dr. Mandar Jog, MD, FRCPC, Professor 
Director, Movement Disorders Program 
London Health Sciences Centre, University Campus and Western University 
INTRODUCTION 
This letter of information describes a research study and what you may expect if you decide to 
participate. You should read the letter carefully and ask the person discussing this with you any 
questions that you may have before making a decision whether or not to participate. This form 
contains important information and telephone numbers, so you should keep this copy for future 
reference. If you decide not to participate in this study, the decision will not be held against you 
and will not affect your treatment in any way. 
You are being asked to participate in this research study because you are an individual with 
oromandibular dystonia (OMD). The purpose of this study is to investigate the effects of 
oromandibular dystonia on your speech intelligibility (how understandable your speech is), your 
level of speech usage, your level of apprehension or concern when you are communicating orally, 
your self-perceived communicative competence, your effectiveness as a communicator in 
different social settings and your quality of life as it relates to communication. An additional 
purpose of this study is to compare how the Botox© injections you are receiving to manage your 
dystonia affects your speech intelligibility, your communicative apprehension, communication 
effectiveness and communication-related quality of life. We are also interested in learning about 
your experience of having oromandibular dystonia. 
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This study will involve 30 participants with OMD. Information about participants will be 
collected from patient charts and person-to-person interviews by the principal experimenter or 
another designated member of the research team. This will include information about the 
participant’s date of birth, general medical history, neurological history, and speech and hearing 
history. 
This study will be conducted over two sessions, separated by approximately one month and 
lasting approximately 40 minutes for the first visit and approximately 2 hours for the second visit. 
Both visits will involve speech recordings of your voice. During this 10 minute recording period 
you will be asked to read aloud a series of 57 single words and 11 sentences while being recorded 
with a microphone. Both visits will also involve completing a series of six questionnaires that will 
look at how you use your speech on a daily basis, your level of concern or apprehension when 
you are communicating orally, your self-perceived competence when communicating, your 
effectiveness as a communicator in different social situations and your quality of life as it relates 
to your communication. It is anticipated that completion of the questionnaires will take 
approximately 30 minutes. The second visit will involve an additional 60-90 minute one-time in-
person interview with the researchers into order to learn more about your experiences of living 
with oromandibular dystonia. During this interview we will ask you to share stories and 
information about strategies you have used to help you participate in life activities due to having 
dystonia. We want to hear about strategies that worked well and those that did not work well. In 
particular, we want to hear about things that make you more or less confident about your 
participation in activities. We want to hear your recommendations that you would give to other 
people in similar circumstances. You do not need to answer any questions you do not want to 
answer. The interview will be audio-recorded. Only the researchers will have access to the 
recording of the interview. The audio file would be stored on a secure server at Western 
University. 
The first visit will be completed during your scheduled clinic visit at the Movement Disorders 
Clinic. The second visit will be scheduled approximately one month later to ensure that your 
Botox© treatment is working optimally. 
If you agree to participate you will be able to complete the first visit of the study directly 
following your scheduled appointment time at the Movement Disorders Clinic in a separate 
testing room located within University Hospital. For the second visit of the study you will be 
asked to come to the Principal Investigator’s Lab for repeat administration of questionnaires, 
speech recordings and the in-person interview.  
The experimental procedures will require very little physical effort, and there is no known 
discomfort or risk involved in performing them. You will be seated in a comfortable chair 
throughout the procedures and during the interview and you will be given rest breaks 
approximately every five minutes or more frequently if required. 
The procedures that will be used during this study are experimental in nature and will not provide 
any direct benefit to the participant’s medical condition, however, it is anticipated that results 
from this study may provide important information about the effect of oromandibular dystonia on 
speech intelligibility, one’s perception of their apprehension when communicating orally, their 
level of speech usage, their perception of how effective they are as communicators, and their 
quality of life as it relates to communication. It may also provide important information about the 
effect of Botox© on speech intelligibility, communication apprehension, communicative 
effectiveness and communication-related quality of life. Financial compensation will not be 
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provided upon completion of this study. Parking costs over and above your regular clinic visit at 
the Movement Disorders Clinic will not be reimbursed.  
Participation in this study is voluntary. You may refuse to participate, refuse to answer any 
questions, or withdraw from the study at any time with no effect on your future care. 
All of the information obtained in this study will be held in strict confidence. Your name and any 
identifying information will be removed from the data. If the results of the study are published, 
your name will not be used and no information that discloses your identity will be released or 
published. Representatives of Western University’s Health Sciences Research Ethics Board may 
contact you or require access to your study-related records to monitor the conduct of the research. 
You do not waive any legal rights by signing the consent form. 
Throughout the study, all confidential information and data will be preserved in a locked filing 
cabinet in the Principal Investigator’s laboratory. All study materials will be destroyed after 25 
years. 
If requested, you will be provided with a copy of any publication related to the results of this 
study when it becomes available. 
If you agree to participate in this study, please sign the consent form on the next page. 
Sincerely, 
Allyson Dykstra, PhD Assistant Professor 
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Appendix B 
Consent Form  
 
STUDY TITLE 
The effects botulinum toxin A on speech intelligibility, levels of speech usage, communication 
apprehension, self-perceived communication competence, communicative effectiveness, 
communication-related quality of life and the lived experiences of individuals with 
oromandibular dystonia. 
PRINCIPAL INVESTIGATOR 
Allyson Dykstra, Ph.D. 
Assistant Professor 
School of Communication Sciences and Disorders, Western University 
CO-INVESTIGATOR 
Dr. Mandar Jog, MD, FRCPC, Professor 
Director, Movement Disorders Program 
London Health Sciences Centre, University Campus and Western University 
I have read the Letter of Information, have had the nature of the study explained to me and I agree 
to participate. All questions have been answered to my satisfaction. 
 
__________________________  _____________________  _______________  
Signature of Research Subject   Printed Name      Date 
 
 
_______________________________  ________________________  _________________ 
Signature of Person Obtaining Consent    Printed Name      Date 
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Appendix C 
Ethics Approval Notice
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Appendix D 
Coding Dictionary 
 
  
Code  Definition  
Aesthetics Change in orofacial aesthetics due to OMD 
Avoidance  
Botox Effect of botox injections 
Change of roles Change of role from caregiver/parent/spouse role to care-
receiver, as well as change of role from care-receiver to 
caregiver (from child's perspective), from able bodied to 
disabled, loss of independence  
Communication ability to communicate, conversations, presentations, 
communication that serves a social function  
 
Diagnosis  Medical appointments, medical procedures, assessments, 
treatments, symptoms of OMD, side effects 
 
Disclosure   
Eating  As a result of OMD: difficulty eating, chewing, swallowing, 
choking, aspirating, drooling, strategies used  
Emotional reactions Emotional reactions that result from living with OMD and its 
treatment: Depression/sadness, frustration, fear, anger, shock, 
surprise, excitement, loss, confidence, embarassment, self-
consciousness, uncertainty, denial 
Fatigue  Fatigue due to symptoms related to OMD 
Good stories  
Job Type of employment, loss of employment, job description, 
regaining employment, employment choices, personal meaning 
of employment 
Pain Physical pain: due to dystonic symptoms, botox injections 
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Perceived reactions 
of others 
Reactions of others that are the result of the person's OMD: 
anger, frustration, sadness, helplessness, pity, honesty about the 
impact of OMD 
Perspective  The ability to reflect on experiences as a result of OMD and 
provide perspective on disability, living with a communication 
disorder, experiences unique to OMD, being grateful, second 
chances, giving back 
Resilience  Ability to work through difficult situations, ability to work 
through emotional or physical pain, strength of character, 
outlook, coping mechanisms (eg. humour, trying to cover up 
the problem) 
Social outings  Trips, vacations, parties, gatherings, volunteer work, social 
interactions 
Speech production Aspects of speech production, difficulty producing intelligible 
speech, difficulty being understood by others due to OMD, 
specific aspects of speech production difficulties  
Strategies Strategies used to make speech better, make speech worse, 
alternate ways of communicating  
Strategies to improve 
symptoms of OMD 
Sensory tricks, strategies used to help with non-speech aspects 
of OMD 
Support Relationships and individuals who play a supportive role to the 
individual with OMD. This can take the form of emotional 
support, physical support, supportive environments  
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